Need help choosing the right code?
Ask CasePilot about procedures, modifiers, bundling, and coding guidance.
Try CasePilot© Copyright 2026 American Medical Association. All rights reserved.
A molecular diagnostics test, identified by CPT® Code 83900, involves the amplification of nucleic acid sequences to facilitate the analysis of genetic material. This procedure is crucial for identifying specific genes and proteins, as well as understanding their interactions within cells. Molecular diagnostics focuses on the patterns of gene and protein activity, allowing for the detection of changes that may indicate the presence of diseases such as cancer, infections, and various genetic disorders, including hematological and neurological conditions. The process begins with the collection of a biological sample, which may include blood, urine, sputum, or tissue. Following sample collection, the nucleic acid—either DNA or RNA—is isolated and prepared for amplification. The target amplification process generates multiple copies of the selected nucleic acid sequence, enabling further analysis. This amplification can be repeated to produce even more copies, enhancing the sensitivity of the test. When multiple nucleic acid sequences are involved, the first two sequences are reported using CPT® Code 83900, while additional sequences are reported with CPT® Code 83901. The use of multiplex technology, which allows for the simultaneous amplification of numerous targets—potentially up to 100 or more—demonstrates the advanced capabilities of molecular diagnostics in modern medicine.
© Copyright 2026 Coding Ahead. All rights reserved.
The molecular diagnostics test using CPT® Code 83900 is indicated for various clinical scenarios, particularly when there is a need to identify specific genetic material associated with diseases. The following conditions may warrant the use of this procedure:
The procedure for molecular diagnostics using CPT® Code 83900 involves several key steps, each critical to the successful amplification and analysis of nucleic acid sequences. The following outlines the procedural steps:
After the molecular diagnostics procedure is completed, the results are analyzed and interpreted by qualified healthcare professionals. The findings can provide critical information for diagnosing diseases, guiding treatment decisions, and informing patient management strategies. It is important to ensure that the results are communicated effectively to the healthcare team and the patient. Follow-up care may be necessary depending on the outcomes of the test, particularly if a diagnosis of a serious condition, such as cancer or a genetic disorder, is made. Additionally, proper documentation of the procedure and results is essential for compliance and billing purposes.
| Short Descr | MOLECULE NUCLEIC AMPLI 2 SEQ | Medium Descr | MOLECULAR DX AMP TARGET MULTIPLEX 1ST 2 SEQ | Long Descr | Molecular diagnostics; amplification, target, multiplex, first 2 nucleic acid sequences | Status Code | Statutory Exclusion (from MPFS, may be paid under other methodologies) | Global Days | XXX - Global Concept Does Not Apply | PC/TC Indicator (26, TC) | 9 - Not Applicable | Multiple Procedures (51) | 9 - Concept does not apply. | Bilateral Surgery (50) | 9 - Concept does not apply. | Physician Supervisions | 09 - Concept does not apply. | Assistant Surgeon (80, 82) | 9 - Concept does not apply. | Co-Surgeons (62) | 9 - Concept does not apply. | Team Surgery (66) | 9 - Concept does not apply. | Diagnostic Imaging Family | 99 - Concept Does Not Apply | APC Status Indicator | Discontinued Code | Type of Service (TOS) | 5 - Diagnostic Laboratory | Berenson-Eggers TOS (BETOS) | none | MUE | Not applicable/unspecified. | CCS Clinical Classification | 233 - Laboratory - Chemistry and Hematology |
Get instant expert-level medical coding assistance.